SCOPUS 정보 검색 플랫폼

Volumn 47, Issue 2-3, 2001, Pages 281-292

Antipsychotic prescription use and costs for persons with schizophrenia in the 1990s: Current trends and five year time series forecasts

(3) Martin, Bradley C a Miller, L Stephen b Kotzan, Jeffrey A a

a UNIVERSITY OF GEORGIA (United States)

b NONE (United States)

Author keywords

(Schizophrenia); Antipsychotic; Atypicals; Economics; Neuroleptic

Indexed keywords

CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; DECANOIC ACID; FLUPHENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; HALOPERIDOL DECANOATE; LOXAPINE; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PIMOZIDE; PROCHLORPERAZINE; PROMAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG UTILIZATION; FEMALE; FORECASTING; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; RACE; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; FEMALE; GEORGIA; HUMANS; LONGITUDINAL STUDIES; MALE; PRESCRIPTION FEES; SCHIZOPHRENIA; TIME FACTORS;

EID: 0035280659 PISSN: 09209964 EISSN: None Source Type: Journal
DOI: 10.1016/S0920-9964(00)00108-0 Document Type: Article

Times cited : (39)

References (26)

1
- 0032980020
- Atypical Antipsychotics: Part II Adverse Effects, Drug Interaction, and Costs
- (1999) Ann. Pharmacother. , vol.33 , pp. 210-217
- Brown, C.S.¹ Markowitz, J.S.² Moore, T.R.³ Parker, N.G.⁴

2
- 0004168027
- Univariate Tests for Time Series Models
- Thousand Oaks, CA
- (1994) Sage University Paper Series on Quantitative Applications in the Social Sciences 07-099
- Cromwell, J.B.¹ Labys, W.C.² Terraza, M.³

3
- 0027985147
- Economics and schizophrenia: The real cost
- (1994) Br. J. Psychiatry , vol.165 , pp. 18-21
- Davies, L.M.¹ Drummond, M.F.²

4
- 0028904587
- Costs of schizophrenia in The Netherlands
- (1995) Schizophr. Bull. , vol.21 , pp. 141-153
- Evers, S.M.A.A.¹ Ament, A.J.H.A.²

5
- 0032979195
- Treatment of Schizophrenia 1999
- (1999) J. Clin. Psychiatry , vol.60 , Issue.SUPPL. 11 , pp. 1-80

6
- 0005640274
- Georgia Department of Medical Assistance, Atlanta, GA
- (1997) Part II Policies and Procedures for Pharmacy Services, Revised April 1

7
- 0005540516
- Georgia Department of Medical Assistance, Atlanta, GA
- (1998) Part II Policies and Procedures for Pharmacy Services, Revised April 1

8
- 0029846685
- A pharmacoeconomic model of outpatient antipsychotic therapy in 'revolving door' schizophrenic patients
- (1996) J. Clin. Psychiatry , vol.57 , pp. 337-345
- Glazer, W.M.¹ Ereshefsky, L.²

9
- 0003905453
- (1998) Statistical Tables

10
- 0002946497
- Schizophrenic disorders
- Robins L.N. Regier D.A. (Eds.). Free Press New York, NY
- (1991) Psychiatric Disorders in America: The Epidemiologic Catchment Area Study , pp. 32
- Keith, S.J.¹ Regier, D.A.² Rae, D.S.³

11
- 0031614053
- At issue: Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations
- (1998) Schizophr. Bull. , vol.24 , pp. 1-10
- Lehman, A.E.¹ Steinwachs, D.M.²

12
- 0031908597
- Patterns of usual care for schizophrenia: Initial results form the Schizophrenia Patient Outcomes Research Team (PORT) client survey
- (1998) Schizophr. Bull. , vol.24 , pp. 11-20
- Lehman, A.E.¹ Steinwachs, D.M.²

13
- 0026543960
- Accuracy of diagnoses of schizophrenia in Medicaid claims
- (1992) Hosp. Community Psychiatry , vol.43 , pp. 69-71
- Lurie, N.¹ Popkin, M.² Dysken, M.³ Moscovice, I.⁴ Finch, M.⁵

14
- 0004182723
- US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Rockville, MD
- (1996) National Expenditures for Mental Health, Alcohol and Other Drug Abuse Treatment 1996
- Mark, T.¹ McKusick, D.² King, E.³ Harwood, H.⁴ Genuardi, J.⁵

15
- 0032950969
- Atypical antipsychotics: Part I Pharmacology, pharmacokinetics, and efficacy
- (1999) Ann. Pharmacother. , vol.33 , pp. 210-217
- Markowitz, J.S.¹ Brown, C.S.² Moore, T.R.³

16
- 0025949685
- Measuring the economic costs of schizophrenia
- (1991) Schizophr. Bull. , vol.17 , pp. 375-388
- McGuire, T.G.¹

19
- 0027510643
- The de Facto US Mental and Addictive Disorders Service System Epidemiologic Catchment Area Prospective 1-Year Prevalence Rates of Disorders and Services
- (1993) Arch. Gen. Psychiatry , vol.50 , pp. 85-94
- Regier, D.A.¹ Narrow, W.E.² Rae, D.S.³

20
- 0033106328
- Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia
- (1999) Schizophr. Res. , vol.35 , Issue.SUPPL.
- Revicki, D.A.¹

21
- 0025816196
- Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988
- May-June 1991
- (1991) Public Health Rep. , vol.106 , Issue.3 , pp. 280-292
- Rice, D.P.¹ Kelman, S.² Miller, L.³

22
- 0001908323
- The economic burden of schizophrenia
- Bethesda, MD
- (1992) Sixth Biennial Research Conference on the Economics of Mental Health , pp. 1-17
- Rice, D.P.¹ Miller, L.S.²

23
- 0001233135
- The economic burden of schizophrenia: Conceptual and methodological issues and cost estimates
- Moscarelli, M., Rupp, A., Sartorius, N. (Eds.). Wiley New York, NY
- (1996) Schizophrenia: Handbook of Mental Health Economics and Health Policy , vol.1 , pp. 321-334
- Rice, D.P.¹ Miller, L.S.²

24
- 0027192157
- The costs of schizophrenia: Assessing the burden
- (1993) Psychiatr. Clin. North Am. , vol.16 , pp. 413-423
- Rupp, A.¹ Keith, S.J.²

25
- 0004348935
- SAS Institute, Cary, NC
- (1991) SAS/ETS Software: Applications Guide 1, Version 6, first ed.

26
- 0031944668
- Pharmacoeconomics of the new antipsychotics for the treatment of schizophrenia
- (1998) Psychiatr. Clin. North Am. , vol.21 , pp. 181-202
- Zito, J.M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.